LYVE1 and cancer: HA is one of the biopolymers used for cancer cell-specific targeting because overexpressed cancer cell receptors such as cluster determinant 44 (CD44), hyaluronan receptor for endocytosis (HARE), and lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) are reactive to the HA [140,141].